RSS

Pharma Finance and Investment News

Novigenix announces first closing of its $20m Series B round
Novigenix SA, a data-driven precision medicine biotech that develops and commercialises Immuno-Transcriptomic precision oncology solutions, announced first closing of its $20 million Series B financing round with participation from investors. Read more
15 Nov 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Orgenesis secures $50m fund to accelerate growth of point-of-care
Orgenesis and Metalmark Capital Partners announced an investment partnership whereby Metalmark has agreed to make a growth investment of up to USD 50 million in Orgenesis’ US-based point of care services subsidiary, Morgenesis. Read more
11 Nov 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Cytiva opens Cell Culture Center of Excellence in Massachusetts
Cytiva opened a new Cell Culture Center of Excellence at its Marlborough, Massachusetts location, part of the company’s long term growth strategy to provide expanded cell culture media development capabilities and new cell line development services. Read more
10 Nov 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Avantor extends investment in biopharma market to Dublin, Ireland
Avantor, a global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, opened a new distribution centre in Dublin, Ireland. Read more
9 Nov 2022
Pharma Manufacturing News + Pharma Finance and Investment News
3D genome mapping platform raises £10m in Series A financing
Enhanc3D Genomics, a genomics company unlocking the full potential of the human 3D genome to transform therapeutic development, raises £10 million in Series A financing to accelerate the development of its proprietary technology platform – GenLink3D. Read more
27 Oct 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Micro-Sphere expands HPAPI manufacturing capabilities at Swiss site
Spray drying specialist and capsule filling service contract development and manufacturing organisation (CDMO) Micro-Sphere has invested over €5 million to expand its GMP manufacturing capabilities at its facility in Monteggio, Switzerland. Read more
26 Oct 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Ardena announces major expansion plans for Swedish site
Ardena, a CDMO assisting biopharma companies with services spanning across the development life cycle, is investing into almost trebling the size of its Swedish facility as part of its €35 million investment across its European operations. Read more
25 Oct 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Quotient Sciences completes major expansion of manufacturing facility
Quotient Sciences' £6 million project results in a drug substance manufacturing capability, in Alnwick, UK, that can deliver integrated support for customers from candidate selection through to early clinical development and beyond. Read more
19 Oct 2022
Pharma Manufacturing News + Pharma Finance and Investment News
Fujifilm to establish its first Bio-CDMO site in Japan
FUJIFILM Corporation announces that it will establish the company’s first Japanese Bio-CDMO site in Toyama City, Toyama Prefecture. The new site will be invested by FUJIFILM Toyama Chemical and will be operational in FY2026. Read more
10 Oct 2022
Pharma Manufacturing News + Pharma Finance and Investment News

Latest Pharmaceutical News

Eisai clears all-case study condition for antiepileptic agent Inovelon
Eisai Co. has received notification from MHLW that the "all-case study" for approval of antiepileptic agent Inovelon Tablets (rufinamide) as an adjunctive therapy to other antiepileptic drugs (AEDs) for treatment of LGS has been cleared. Read more
25 Nov 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Bormioli & Pierre Fabre develop 100% recycled PET packaging for mouthwash
Bormioli Pharma and Pierre Fabre have developed an innovative 100% recycled PET packaging for the mouthwashes of the ELUDRIL brand, a European specialist in oral care within the pharmacy channel. Read more
25 Nov 2022
Pharma Manufacturing News + Pharmaceutical Packaging News
Pivotal partnership seeks to transform Cystic Fibrosis research
LifeArc, a national medical research charity, joined the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate in a strategic partnership alongside Cystic Fibrosis Trust and Medicines Discovery Catapult (MDC). Read more
24 Nov 2022
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Novel drug combination progresses to Phase 3 for uncomplicated malaria
Novartis and MMV announce the decision to progress ganaplacide/lumefantrine- solid dispersion formulation (SDF) into Phase 3 development for the treatment of patients with acute uncomplicated malaria due to Plasmodium falciparum. Read more
24 Nov 2022
Pharma Manufacturing News + New Drug Development & Regulatory News
Airnov celebrates five years of manufacturing in India
Airnov Healthcare Packaging, a specialist in controlled atmosphere packaging, has surpassed five years of manufacturing at its production facility in India, and announces it participation to CPhI India 2022. Read more
18 Nov 2022
Pharma Manufacturing News + Pharmaceutical Packaging News
Positive NICE recommendation for Takeda’s treatment for rare lung cancer
NICE has published a positive recommendation for EXKIVITY (mobocertinib) for treating EGFR Exon 20 insertion mutation-positive advanced non-small-cell lung cancer after platinum-based chemotherapy within a Final Appraisal Document (FAD). Read more
17 Nov 2022
Pharma Manufacturing News + New Drug Development & Regulatory News